AZN
AstraZeneca PLCNYSE
Healthcare • Drug Manufacturers - General
Updated 1 day ago
Coverage ready
$155.82-1.59%
Close Oct 13, 2026
- Market cap
- $243.08B
- 1 month
- -4.9%
- 3 months
- -7.5%
- 1 year
- -7.8%
- Dividend, last 12 mo
- None in the last year
- Last ex-date
- Aug 8, 2025 · $0.515
- Dividend growth
- 1 year in a row
- Short interest
- 2.6M sharessettled Sep 30, 2026 · +25.4% since Sep 15, 2026 · FINRA
End-of-day close from stored market data, not a live quote.
Portfolio context
Sign in to see your position size
We’ll show you if AZN is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
Smart money context
Holder IQ: LOW
6 top institutions tracked
as of 2026-Q2 (filed 2026-08-20)
Insider context
Sentiment: neutral
Last trade: buy 33 days ago
Red flags: 3
Largest 13-F holders · Q2 2026
27 filers reported a long position in AZN for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Mediolanum International Funds Ltd | $92.3M | 487.4K | New |
| FAYEZ SAROFIM & CO | $34.1M | 179.6K | New |
| Mengis Capital Management, Inc. | $8.9M | 46.7K | +0.1% |
| Wahed Invest LLC | $8.3M | 44.3K | +25.9% |
| Stanley-Laman Group, Ltd. | $4.5M | 23.6K | -1.9% |
| WESTPORT ASSET MANAGEMENT INC | $1.4M | 7.5K | Unchanged |
| RAELIPSKIE PARTNERSHIP | $1.4M | 7.4K | Unchanged |
| A. D. Beadell Investment Counsel, Inc. | $1.3M | 7K | Unchanged |
| Harvest Fund Management Co., Ltd | $978K | 5.2K | Unchanged |
| 1620 INVESTMENT ADVISORS, INC. | $959.2K | 5.1K | +0.6% |
Get the Full Analysis for AZN
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.